Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2017-09-04 Earnings Release
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
Preliminary Results Announcement -year end 30.6.17
Earnings Release Classification · 100% confidence The document is titled 'Preliminary Results Announcement' and contains detailed financial summaries, highlights, and commentary on performance for the year ended 30 June 2017. It explicitly mentions 'audited preliminary results' and provides extensive financial tables (Revenue, Operating profit, EPS, Dividend) and segment analysis (EU Pharmaceuticals, North America Pharmaceuticals). This content strongly indicates a comprehensive annual financial disclosure, which aligns with the definition of an Annual Report (10-K). However, since this is a 'Preliminary Results Announcement' published via RNS (Regulatory Information Service) and is often the precursor or a summary version of the full 10-K, it must be classified based on the provided definitions. The content is far too detailed to be a simple Earnings Release (ER) or a Report Publication Announcement (RPA). Given the depth of the financial data and the reference to 'audited preliminary results', it is most closely aligned with the comprehensive reporting expected in an Annual Report (10-K) or a very detailed Interim/Quarterly Report (IR). Since the period covered is a full fiscal year ('year ended 30 June 2017'), 10-K is the most appropriate classification for a full-year financial disclosure, even if it is labeled 'Preliminary Results Announcement' which often precedes the final 10-K filing. FY 2017
2017-09-04 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly mentions 'RNS Number : 4191P' and states, 'the Company notifies the market of the following: ... Therefore, the total number of Ordinary Shares with voting rights is 93,181,408.' This content relates to the total voting rights, which is a mandatory disclosure under regulatory rules (DTR 5.6.1R). While it contains voting rights information, it is structured as a general regulatory notification disseminated via the RNS service. The definitions provided categorize 'Declaration of Voting Results & Voting Rights Announcements' as DVA, but this document is a notification of the *denominator* for voting rights calculations, not the *results* of a vote. Given the explicit 'RNS Number' and the nature of the disclosure (a routine regulatory update disseminated through the RNS system), the most appropriate classification is Regulatory Filings (RNS), which serves as the general regulatory announcement category.
2017-08-31 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document contains an 'RNS Number' and explicitly states 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content is a mandatory regulatory filing about shareholding thresholds being crossed, making MRQ the most precise classification over the general RNS fallback.
2017-08-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly labeled with 'RNS Number : 0613M' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is distributed via RNS, the specific content dictates the classification over the general RNS fallback. The content details the resulting situation (7.13% total) and the previous situation (5.36%) after an acquisition/disposal of voting rights for Dechra Pharmaceuticals PLC by BlackRock, Inc., confirming it is a major holding notification.
2017-07-25 English
Trading Update & Notice of Annual Results
Earnings Release Classification · 98% confidence The document is identified by the RNS Number (RNS Number : 2572K) and explicitly states it is a 'Trading Update' for the financial year ended 30 June 2017, issued ahead of the preliminary financial results announcement. It provides key financial highlights (revenue growth percentages) and operational summaries. The presence of the RNS header and the concluding statement 'This information is provided by RNS' strongly suggests it is a regulatory announcement. Since it is a trading update providing preliminary financial highlights before the full report, it fits best under the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights only). It is not the full report (10-K or IR), nor is it a general announcement of a report's publication (RPA), as it contains substantive financial data itself. FY 2017
2017-07-06 English
Total Voting Rights
Regulatory Filings Classification · 98% confidence The document explicitly starts with an 'RNS Number' and contains language typical of regulatory notifications to the market, specifically referencing 'DTR 5.6.1R' (Disclosure and Transparency Rules). The core content is the notification of the 'Total Voting Rights' and the total number of ordinary shares with voting rights (93,178,756). This type of mandatory disclosure regarding share capital structure and voting rights, especially when issued via the RNS system, fits best under the general 'Regulatory Filings' category, as there is no specific code for 'Total Voting Rights' notification, and it is not a declaration of voting results (DVA) but a statement of the denominator for future calculations. Given the source (RNS Number) and the nature of the announcement, RNS is the most appropriate classification.
2017-06-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.